Banking Covenant Update
Market Announcement
28 October 2021
13610443_1
BANKING COVENANT UPDATE
Further to the announcement of 31 August 2021, Promisia Healthcare Limited (NZX:PHL) can advise
that it has now concluded a constructive dialogue with the BNZ regarding its banking covenants.
As previously advised, the company was in breach of its EBITDA / Interest covenant for the quarter
ended 30 June 2021. Under this covenant EBITDA was to be at least twice interest costs. Discussions
with the BNZ included questioning whether the covenants were set at the appropriate level. In
addition, the company advised that at the current levels a further breach of the EBITDA / Interest
covenant for the September quarter will occur. The BNZ has advised in writing today that the
EBITDA/Interest covenant will remain in place at the same level and, accordingly, the company
advises that it has breached the EBITDA/Interest covenant for the quarter ended 30 September
2021. The BNZ has advised that it will not be taking any action at this time in respect of a breach for
either the June or September quarters but does reserve all of its rights with respect to the breaches.
In reviewing the June quarterly covenant reporting a breach of the Total Debt / Total Assets
Covenant given by the company was also discovered. Under this covenant the company’s total debt
is to not exceed 71% of total assets at all times. The company had considered that it complied with
this covenant but was calculating this covenant on the basis of total interest-bearing debt. However,
the BNZ calculated this covenant on the basis of total liabilities, meaning that all trade creditors,
general provisions, lease commitments reported under IFRS16, as well as residual liabilities under
occupation right agreements needed to be factored in. This is despite the liabilities under occupation
right agreements only needing to be satisfied when a new occupation right agreement is sold.
Using the BNZ’s calculation the Total Debt / Total Assets position for the June quarter was 71.07%.
The BNZ has provided a waiver of this covenant for the June quarter and removed this covenant as
an ongoing requirement for the company.
For further information please contact Mr Stephen Underwood, Chairman, on Ph 027 499 3387
ENDS
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: AFT reaffirms guidance and progresses growth plan2021-11-17
“AFT PHARMACEUTICALS LIMITED Condensed Consolidated Interim Financial Statements The Group has one significant concentration of credit risk at 30 September 2021, with the largest debtor being AU$4.4m (31 March 2021: AU$11.5m). There has been no past experience of default and no…”
- ANZ — ANZ Group Holdings Limited: ANZ NZ Branch DS 30 September 20212021-11-10
“AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED - ANZ NEW ZEALAND 2021 DISCLOSURE STATEMENT NOTES TO THE FINANCIAL STATEMENTS 68 27. COMMITMENTS AND CONTINGENT LIABILITIES (continued) OTHER CONTINGENT LIABILITIES There are outstanding court proceedings, claims and p…”
- ANZ — ANZ Group Holdings Limited: ANZ Bank New Zealand Disclosure Statement2021-11-10
“ANZ BANK NEW ZEALAND LIMITED 2021 ANNUAL REPORT NOTES TO THE FINANCIAL STATEMENTS 68 27. COMMITMENTS AND CONTINGENT LIABILITIES (continued) OTHER CONTINGENT LIABILITIES There are outstanding court proceedings, claims and possible claims for and against the Banking G…”